British Lung Foundation News Monitoring

Get by Email • RSS

Published on May 24, 2025

The Cost-Effectiveness of a Personalised Early Warning Decision Support System (The COPDPredict™ System) to Predict and ...

Introduction Chronic obstructive pulmonary disease (COPD) is a progressive lung disease affecting tens of millions of adults globally.1 The disease is accompanied by recurring acute exacerbations (AECOPD), that lead to clinical deterioration, and when …

Source: Dove Medical Press - Neutral

01 days 23:46:35

Featured Releases

Got News to Share? · Submit · See All

Published on May 21, 2025 - 12:45 GMT

Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung ...

GRAND CAYMAN, Cayman Islands, May 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …

Distribution channels:
Published on May 23, 2025 - 16:26 GMT

Mainstreaming Women's Health in Congress with the First-Ever Women's Health Capitol Hill Day

First-ever Women's Health Capitol Hill Day includes Congressional Briefing with Experts Highlighting Gaps and Opportunities to Advance the Health of Women WASHINGTON, DC, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- On May 21st, Women’s …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 23, 2025 - 00:00 GMT

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new data from several studies of compounds discovered by HUTCHMED including …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 22, 2025 - 21:15 GMT

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b ...

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 22, 2025 - 21:31 GMT

Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20% Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advanced Melanoma Previously Treated with Immune Checkpoint Inhibitor SAN CARLOS, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 22, 2025 - 21:15 GMT

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® infusion New data at ASCO from the CARTITUDE-4 study …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 22, 2025 - 21:03 GMT

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...
Published on May 22, 2025 - 21:05 GMT

Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American ...

AMSTERDAM, May 22, 2025 (GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new dual agonistic, multifunctional antibody modality with broad applicability in oncology, today announced its upcoming presentation at the 2025 American …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 815,869,219 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 24, 2025 - 19:44 GMT

DMARC MSP Case Study: 1-MSP Boosts Client Security & Deliverability with PowerDMARC

ORLANDO, FL, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- As email threats continue to rise, managed service providers are under growing pressure to deliver scalable, effective domain protection to clients. 1-MSP, a leading US-based managed …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 17:47 GMT

Rx-Credentialing Achieves Milestone: Over 100 NPs and MDs Engaged with High Retention Rates

Premium Medical Billing Service is proud to announce that the company now serves over 100 nurse practitioners (NPs) and medical doctors (MDs) across New York. NEW YORK , NY, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- RxCredentialing, a …

Distribution channels: Business & Economy, Companies ...
Published on May 24, 2025 - 17:38 GMT

Blue Sky Scrubs Unveils the Trinity Layering Scrubs Top: Ultra-Smooth, Stretchy, and Dreamy to the Touch

Blue Sky Scrubs Unveils the Trinity Layering Scrubs Top: Ultra-Smooth, Stretchy, and Dreamy to the Touch- Since 2005 Boutique Scrubs Designed In Austin, Texas AUSTIN, TX, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- Blue Sky Scrubs, a …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 17:22 GMT

Bridging the Gap in Schizophrenia Care: A Call for Comprehensive Rehabilitation in India

MindPlus, a regional pioneer in holistic mental health care, organized session today at MindPlus Doraha to mark World Schizophrenia Day. LUDHIANA, PUNJAB, INDIA, May 24, 2025 /⁨EINPresswire.com⁩/ -- On the occasion of World Schizophrenia Day, observed …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 17:16 GMT

Village Emergency Room & Urgent ER Care Clinic Enhances 24/7 Access to Emergency Services in League City

LEAGUE CITY, TX, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- Village Emergency Room & Urgent ER Care Clinic, located at 3725 E League City Parkway #150, has reaffirmed its commitment to the League City and Clear Creek community by …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on May 24, 2025 - 16:34 GMT

New Comprehensive Rodent Models Developed by Creative Biolabs Aim to Improve Disease Research

Creative Biolabs has recently expanded its research in non-transgenic rodent models to meet the growing diversity of non-clinical study needs. SHIRLEY, NY, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- Creative Biolabs has recently expanded …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on May 24, 2025 - 16:29 GMT

Creative Diagnostics Advances Influenza Antiviral Drug Discovery with Comprehensive Screening and Evaluation Services

Creative Diagnostics has announced its comprehensive suite of services for Influenza Antiviral Drug Screening and Evaluation. NEW YORK, NY, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- As an expert in providing solutions to assist virology …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 16:29 GMT

Creative Diagnostics Launches Highly Sensitive T7 RNA Polymerase ELISA Kits for Biopharmaceutical Impurity Detection

Creative Diagnostics has released T7 RNA Polymerase ELISA Kits for the detection and quantitative determination of T7 RNA Polymerase. NEW YORK, NY, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- Creative Diagnostics, a leading manufacturer …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 23:17 GMT

SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pä...

– im Falle einer Marktzulassung wäre Mirdametinib die erste und einzige Behandlung in der Europäischen Union für Erwachsene und Kinder mit NF1-PN – – die Entscheidung der Europäischen Kommission wird für das dritte Quartal 2025 erwartet – STAMFORD, Conn., …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 24, 2025 - 23:17 GMT

SpringWorks Therapeutics recibe un dictamen positivo del CHMP para el uso de mirdametinib en el tratamiento de la NF1-NP ...

– Si se aprueba, se espera que el mirdametinib sea la primera y única terapia autorizada para el tratamiento de la NF1-NP en la Unión Europea, tanto para adultos como para niños – – Decisión de la Comisión Europea prevista en el tercer trimestre de 2025 – …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 24, 2025 - 23:17 GMT

SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des ...

– S’il est approuvé, le mirdamétinib devrait être le premier et unique traitement dans l’Union européenne à bénéficier d’une autorisation de mise sur le marché pour les adultes et les enfants atteints de NF1-PN – – La décision de la Commission européenne …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 24, 2025 - 23:17 GMT

SpringWorks Therapeutics: CHMP valuta positivamente Mirdametinib per il trattamento di pazienti adulti e pediatrici ...

– Se approvato, mirdametinib sarà la prima e unica terapia nell'Unione europea a ottenere l'autorizzazione all'immissione in commercio sia per gli adulti che per i bambini affetti da NF1-PN – – La decisione della Commissione europea è prevista …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 24, 2025 - 23:17 GMT

SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling van volwassen en ...

- Als mirdametinib wordt goedgekeurd, zal het naar verwachting de eerste en enige therapie in de Europese Unie zijn met een handelsvergunning voor zowel volwassenen als kinderen met NF1-PN - - Besluit van de Europese Commissie wordt verwacht in het derde …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 24, 2025 - 00:00 GMT

Now Accepting Applications: iHope Genetic Health Clinical Sites

Pass it on! DAMASCUS, MD, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- Genetic Alliance is now accepting applications for new clinical sites to join the iHope Genetic Health (iGH) program, which provides no-cost genomic testing to families from low …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 23:28 GMT

ACHS Welcomes My Vinyasa Practice as a New Marketplace Partner

ACHS partners with My Vinyasa Practice to expand wellness education access & offer exclusive benefits that support holistic health careers & lifelong learning. PORTLAND, OR, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- American …

Distribution channels: Business & Economy, Consumer Goods ...
Published on May 23, 2025 - 20:32 GMT

New Book ‘The Healthiest Human’ Offers Science-Based Guide to Optimal Wellness

“The Healthiest Human: The Guide to Optimal Health and Wellness” by Guy Millward Now Available on Amazon and Digital Platforms UNITED KINGDOM, May 23, 2025 /⁨EINPresswire.com⁩/ -- “The Healthiest Human: The Guide to Optimal Health and Wellness,” a new …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...
Published on May 23, 2025 - 20:07 GMT

Sample Sale Spectacle: Murray Hill Optical Launches with Weeklong Event Featuring Deep Discounts and Designer Finds

Score designer frames up to 80% off during Murray Hill Optical’s grand opening sample sale, May 28–June 4 at 500 3rd Ave, NYC. Style, prizes, and vision await! NEW YORK, NY, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- A Fresh Start, A Limited-Time …

Distribution channels: Business & Economy, Consumer Goods ...
Published on May 24, 2025 - 07:49 GMT

Vorläufige Ergebnisse von Merus zu Petosemtamab mit Pembrolizumab zeigen robuste Wirksamkeit und Dauerhaftigkeit bei der ...

- 63%ige Ansprechrate bei 24 auswertbaren Patienten beobachtet - 79%ige Gesamtüberlebensrate nach 12 Monaten; 9 Monate medianes progressionsfreies Überleben - Telefonkonferenz am Donnerstag, 22. Mai, um 17:30 Uhr (Eastern Time) UTRECHT, Niederlande, und …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 24, 2025 - 07:49 GMT

Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent une réelle efficacité...

- Taux de réponse de 63 % observé chez les 43 patients évaluables - Taux de survie général de 79 % au bout de 12 mois ; survie sans progression de niveau moyen à 9 mois - Conférence téléphonique le jeudi 22 mai à 17 h 30 heure de l’Est UTRECHT, Pays-Bas et …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 23, 2025 - 19:36 GMT

DiaGen Ai Inc. Announces JV with Contango Labs to Launch its First Decentralized Drug Discovery Miner on Bittensor $TAO

DiaGen Ai Inc., Announces Partnership with Contango Labs and Provides Update and Upsizing of its Seed Unit Financing VANCOUVER, BC, CANADA, May 23, 2025 /⁨EINPresswire.com⁩/ -- DiaGen Ai Inc., Announces Partnership with Contango Labs Launching its …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...